131 related articles for article (PubMed ID: 11405348)
1. Newborn mass screening versus selective investigation: benefits and costs.
Pollitt RJ
J Inherit Metab Dis; 2001 Apr; 24(2):299-302. PubMed ID: 11405348
[TBL] [Abstract][Full Text] [Related]
2. Newborn screening for inborn errors of metabolism: a systematic review.
Seymour CA; Thomason MJ; Chalmers RA; Addison GM; Bain MD; Cockburn F; Littlejohns P; Lord J; Wilcox AH
Health Technol Assess; 1997; 1(11):i-iv, 1-95. PubMed ID: 9483156
[TBL] [Abstract][Full Text] [Related]
3. Neonatal screening for inborn errors of metabolism: cost, yield and outcome.
Pollitt RJ; Green A; McCabe CJ; Booth A; Cooper NJ; Leonard JV; Nicholl J; Nicholson P; Tunaley JR; Virdi NK
Health Technol Assess; 1997; 1(7):i-iv, 1-202. PubMed ID: 9483160
[TBL] [Abstract][Full Text] [Related]
4. Clinical effectiveness and cost-effectiveness of neonatal screening for inborn errors of metabolism using tandem mass spectrometry: a systematic review.
Pandor A; Eastham J; Beverley C; Chilcott J; Paisley S
Health Technol Assess; 2004 Mar; 8(12):iii, 1-121. PubMed ID: 14982654
[TBL] [Abstract][Full Text] [Related]
5. The cost-effectiveness of expanding newborn screening for up to 21 inherited metabolic disorders using tandem mass spectrometry: results from a decision-analytic model.
Cipriano LE; Rupar CA; Zaric GS
Value Health; 2007; 10(2):83-97. PubMed ID: 17391418
[TBL] [Abstract][Full Text] [Related]
6. Newborn screening by tandem mass spectrometry for medium-chain Acyl-CoA dehydrogenase deficiency: a cost-effectiveness analysis.
Venditti LN; Venditti CP; Berry GT; Kaplan PB; Kaye EM; Glick H; Stanley CA
Pediatrics; 2003 Nov; 112(5):1005-15. PubMed ID: 14595039
[TBL] [Abstract][Full Text] [Related]
7. Expanding screening for rare metabolic disease in the newborn: an analysis of costs, effect and ethical consequences for decision-making in Finland.
Autti-Rämö I; Mäkelä M; Sintonen H; Koskinen H; Laajalahti L; Halila R; Kääriäinen H; Lapatto R; Näntö-Salonen K; Pulkki K; Renlund M; Salo M; Tyni T
Acta Paediatr; 2005 Aug; 94(8):1126-36. PubMed ID: 16188860
[TBL] [Abstract][Full Text] [Related]
8. An Economic Evaluation of Neonatal Screening for Inborn Errors of Metabolism Using Tandem Mass Spectrometry in Thailand.
Thiboonboon K; Leelahavarong P; Wattanasirichaigoon D; Vatanavicharn N; Wasant P; Shotelersuk V; Pangkanon S; Kuptanon C; Chaisomchit S; Teerawattananon Y
PLoS One; 2015; 10(8):e0134782. PubMed ID: 26258410
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and outcome of expanded newborn screening for metabolic diseases--report of 10 years from South-West Germany.
Lindner M; Gramer G; Haege G; Fang-Hoffmann J; Schwab KO; Tacke U; Trefz FK; Mengel E; Wendel U; Leichsenring M; Burgard P; Hoffmann GF
Orphanet J Rare Dis; 2011 Jun; 6():44. PubMed ID: 21689452
[TBL] [Abstract][Full Text] [Related]
10. Newborn screening.
Wilcken B; Wiley V
Pathology; 2008 Feb; 40(2):104-15. PubMed ID: 18203033
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive cost-utility analysis of newborn screening strategies.
Carroll AE; Downs SM
Pediatrics; 2006 May; 117(5 Pt 2):S287-95. PubMed ID: 16735255
[TBL] [Abstract][Full Text] [Related]
12. [Screening of newborns for inborn errors of metabolism by tandem mass spectrometry].
Simonsen H
Ugeskr Laeger; 2002 Nov; 164(48):5607-12. PubMed ID: 12523003
[TBL] [Abstract][Full Text] [Related]
13. Newborn screening with tandem mass spectrometry: examining its cost-effectiveness in the Wisconsin Newborn Screening Panel.
Insinga RP; Laessig RH; Hoffman GL
J Pediatr; 2002 Oct; 141(4):524-31. PubMed ID: 12378192
[TBL] [Abstract][Full Text] [Related]
14. Newborn screening for metabolic diseases: saving children's lives and improving outcomes.
Bennett MJ
Clin Biochem; 2014 Jun; 47(9):693-4. PubMed ID: 24886768
[TBL] [Abstract][Full Text] [Related]
15. Cost-benefit analysis: newborn screening for inborn errors of metabolism in Lebanon.
Khneisser I; Adib S; Assaad S; Megarbane A; Karam P
J Med Screen; 2015 Dec; 22(4):182-6. PubMed ID: 26062758
[TBL] [Abstract][Full Text] [Related]
16. Clinical efficacy and cost-effectiveness of newborn screening for medium chain acyl-CoA dehydrogenase deficiency using tandem mass spectrometry.
Tran K; Banerjee S; Li H; Noorani HZ; Mensinkai S; Dooley K
Clin Biochem; 2007 Feb; 40(3-4):235-41. PubMed ID: 17222812
[TBL] [Abstract][Full Text] [Related]
17. [Tandem mass spectrometry as screening for inborn errors of metabolism].
Campos H D
Rev Med Chil; 2011 Oct; 139(10):1356-64. PubMed ID: 22286738
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis of very long chain acyl-dehydrogenase deficiency from an infant's newborn screening card.
Wood JC; Magera MJ; Rinaldo P; Seashore MR; Strauss AW; Friedman A
Pediatrics; 2001 Jul; 108(1):E19. PubMed ID: 11433098
[TBL] [Abstract][Full Text] [Related]
19. Expanded newborn screening for inborn errors of metabolism by electrospray ionization-tandem mass spectrometry: results, outcome, and implications.
Schulze A; Lindner M; Kohlmüller D; Olgemöller K; Mayatepek E; Hoffmann GF
Pediatrics; 2003 Jun; 111(6 Pt 1):1399-406. PubMed ID: 12777559
[TBL] [Abstract][Full Text] [Related]
20. Economic evaluation of tandem mass spectrometry newborn screening in Australia.
Norman R; Haas M; Chaplin M; Joy P; Wilcken B
Pediatrics; 2009 Feb; 123(2):451-7. PubMed ID: 19171609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
